Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-12-10

Clinical Trial Update: Clinical Trial of Dipyridamole in Schizophrenia [NA]

View source ↗

Summary

Clinical trial of dipyridamole in schizophrenia and schizoaffective disorder completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dipyridamole (Dipyridamole)

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Schizophrenia, Schizoaffective Disorder | NA | Status: COMPLETED | Results posted: 2018-12-10